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Abstract
Background: Chronic fatigue syndrome (CFS, also known as myalgic encephalomyelitis (ME)) is defined as fatigue
that is disabling, is accompanied by additional symptoms and persists for ≥ 4 months. Treatment of CFS/ME aims to
help patients manage their symptoms and make lifestyle adjustments. We do not know whether intervening early
in primary care (< 4 months after onset of fatigue) can prevent the development of CFS/ME.
Methods: This was a feasibility randomised controlled trial with adults (age ≥ 18 years) comparing usual care with
usual care plus an early intervention (EI; a combination of psycho-education and cognitive behavioural therapy,
CBT). This study took place in fourteen primary care practices in Bristol, England and aimed to identify issues
around recruitment and retention for a full-scale trial. It was not powered to support statistical analysis of
differences in outcomes. Integrated qualitative methodology was used to explore the feasibility and acceptability of
recruitment and randomisation to the intervention.
Results: Forty-four patients were recruited (1 August 2012–November 28, 2013), falling short of our predicted
recruitment rate of 100 patients in 8 months. Qualitative data from GPs showed recruitment was not feasible
because it was difficult to identify potential participants within 4 months of symptom onset. Some referring GPs felt
screening investigations recommended by NICE were unnecessary, and they had difficulty finding patients who
met the eligibility criteria. Qualitative data from some participant interviews suggested that the intervention was
not acceptable in its current format. Although the majority of participants found parts of the intervention
acceptable, many reported one or more problems with acceptability. Participants who discontinued the
intervention or found it problematic did not relate to the therapeutic model, disliked telephone consultations or
found self-reflection challenging.
Conclusions: A randomised controlled trial to test an early intervention for fatigue in adults in primary care is not
feasible using this intervention and recruitment strategy.
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Introduction
Fatigue lasting more than 1month is reported by 10–
24% of attendees in general practice [1–3]. The popula-
tion prevalence of chronic fatigue syndrome/myalgic en-
cephalopathy (CFS/ME), where fatigue has persisted
beyond 4months, is 0.2–2%. CFS/ME is a significant
health burden, has a poor prognosis in adults and con-
sumes considerable health resources [4]; however, it is
not known whether early identification and treatment of
disabling fatigue can prevent the onset of CFS/ME.
A study that explored the pathway from glandular fever
to CFS/ME found that 9.4% of (N = 234) participants were
chronically fatigued at 3 months, and 7.8% of participants
met the criteria for CFS/ME at 6months [5]. The conclu-
sions indicated areas for early intervention based on ad-
dressing particular characteristics, including anxiety,
depression, somatization and perfectionism [5]. Address-
ing these ‘predisposing’ factors using cognitive behavioural
approaches could reduce the probability of a patient with
disabling fatigue lasting 1–4months becoming the debili-
tating long-term condition that is CFS/ME.
Evidence to support early intervention was provided
by a small (N = 69) randomised controlled trial based in
primary care, which suggested there were fewer cases of
fatigue (odds ratio 0.31, 95% confidence interval 0.09–
0.91) in patients randomised to a psycho-educational
intervention compared to controls [6]. The psycho-
education was based on a behavioural model of fear
avoidance and suggests recovery may be delayed due to
prolonged rest. This hypothesis is presented to the pa-
tient and a suggested activity plan is given to guide them
on a graded re-introduction of physical activity. How-
ever, we do not know whether this approach translates
to patients presenting with fatigue in general practice or
whether it is only useful in those whose chronic fatigue
has been triggered by glandular fever (or some other
viral infection).
In this study, we report on the feasibility [7] and ac-
ceptability of recruiting participants into a randomised
controlled trial of an early intervention (referred to sub-
sequently as EI) for early-onset, disabling fatigue to in-
form the design of a full-scale trial comparing usual care
with EI plus usual care. The aim of the study is to esti-
mate study parameters including the feasibility of re-
cruitment (including the number of eligible patients
presenting to primary care), the acceptability of the
intervention to patients and the completion of patient-
reported outcome measure results.
Methods
Population
Practices were identified through the Avon Primary Care
Research Collaborative, now called NIHR Clinical Re-
search Network West of England. When a practice
expressed an interest, their deprivation score was
checked using the Public Health Observatories General
Practice Profiles [8] to investigate how representative the
sample of patients was. Practices across Bristol varied in
their deprivation score which reflects population socio-
economic status.
A target of 100 patients was set based on the fact that
approximately a tenth of all GP consultations record a
complaint of fatigue [1, 3]. Assuming each GP practices
had a list of 10,000, this would suggest there would be
5000 appointments in each year per GP practice where
fatigue was discussed [9]. We therefore assumed it
would be feasible to recruit 100 patients in 12months.
Sample size calculations are not always appropriate in
feasibility studies [10]; therefore, this number was con-
sidered adequate to estimate the parameters required to
design a larger trial.
Adults were eligible for this study if they were aged
over 18; reported fatigue for at least 1 month but less
than 4 months; had known causes of fatigue, e.g. cancer
had been excluded; had normal results for the screening
blood tests recommended in National Institute for Clin-
ical Excellence guidance for CFS [1]; and scored ≥ 4 on
the Chalder Fatigue Scale [11].
Patient recruitment
Eligible patients were identified by the consulting GP
and were asked to consent to contact from the research
team. If the patient was willing to find out more about
the study, a researcher contacted him/her and arranged
a visit at a convenient time and location (usually the pa-
tient’s home) to discuss and provide further information
about the study, including the PIS (patient information
sheet), the study rationale, the uncertainties about the
effectiveness of either intervention, the known advan-
tages/disadvantages of the interventions, the options
available outside the study and the right not to take part
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or withdraw at any time and the consent forms. Patients
who were willing to take part were randomised to either
usual care or to usual care plus EI.
Data were requested from each practice on the con-
sultation codes used during the period of the study.
Consultations with the following codes on Egton Med-
ical Information Systems (EMIS) were counted: tired all
the time (TATT), fatigue, exhausted, malaise, and leth-
argy. EMIS records for a sample of the first 100 consul-
tations from one practice from the date they entered the
study were selected for more detailed analysis. The re-
cords were checked retrospectively, against the study eli-
gibility criteria.
GP recruitment
The research team stayed in regular contact with GP
practices to remind them about the study and inform
them when patients were recruited. A laminated flow-
chart for the study was given to each GP. Every GP prac-
tice was visited by a member of the research team at
least once during the study period. A variety of prompts
about the study were used including email, telephone
call and flyers.
Randomisation
Allocation was minimised by gender and age group
retaining a probabilistic element using a computer-
generated random number sequence and was imple-
mented using an automated telephone randomisation
service provided by the Bristol Randomised Trials Col-
laboration (BRTC) to ensure allocation concealment. We
switched recruitment from 1:1 to 1:2 (in favour of EI) in
April 2013 to increase the number of participants who
would experience EI in order to investigate the accept-
ability of the intervention.
Interventions
Usual care
All participants received usual care from their GP. Usual
care is defined by NICE [4] as investigation for other
causes of fatigue (including blood screen), symptomatic
relief through pharmacology and referral on to specialist
services where they exist. GP’s were asked to record the
care given, including referral to other services. We re-
corded the number of participants referred to the re-
gional specialist CFS/ME service.
Early intervention
Participants in the EI arm continued to receive their
usual care from their GP. As part of the EI arm, they
also received: an information booklet; one face-to-face
treatment session (duration up to 1 h); and three tele-
phone follow-up sessions (20 min each) at 2, 6 and 10
weeks. The intervention was started in the participants
home by an experienced, trained CFS/ME therapist
within 2 weeks of randomisation.
EI was adapted from treatment for CFS/ME delivered
by the Bristol CFS/ME service, which follows NICE
guidelines for CFS/ME [4]. EI is based on a cognitive be-
havioural model of fatigue, focusing on strategies to im-
prove sleep (sleep hygiene) and to balance activity (using
activity diaries). The intervention included making a
sleep and rest routine, monitoring the type and amount
of activity undertaken every day and helping to develop
consistent daily activity levels. CBT was used to explore
barriers to getting better including fearful cognitions,
avoidance of perceived risky situations, all-or-nothing
behaviour, inappropriate beliefs about rest and sleep and
focusing only on symptoms as opposed to experiencing
them as normal bodily sensations. Where possible, solu-
tions were discussed with participants. EI treatment ses-
sions were audio-recorded and reviewed by the PI to
ensure adherence to the treatment manual.
Feasibility assessment
We assessed the feasibility of recruitment by assessing
the number recruited and the percentage of potentially
eligible participants recruited. We assessed the accept-
ability of recruitment by interviewing participants over
the recruitment methodology. We assessed the accept-
ability of the intervention by interviewing participants
about the views of the intervention as well as exploring
the numbers that completed the intervention. We
assessed the completion of the patient-reported outcome
measures as an assessment of the acceptability of the
patient-reported outcome measures.
Patient-reported outcome measurement
The following inventories were completed by partici-
pants at their assessment with the researcher (baseline)
and then at 12-week and 6-month follow-up: socio-
economic status (education and employment), Chalder
Fatigue Scale [11], visual analogue pain rating scale [12],
SF-36 physical function sub-scale [13], the Hospital
Anxiety and Depression Scale (HADS) [14], the EQ-5D-
5L [15], an adapted 4-item Work Productivity and Activ-
ity Impairment and General Health (WPAI:GH) ques-
tionnaire [16], and a health resource-use questionnaire,
developed for this study which asked questions about
health service use and travel costs most relevant to the
CFS/ME population.
Reminders were sent out if follow-up questionnaires
had not been returned after 2 weeks, followed by a
phone call to persistent non-responders at 4 weeks,
during which questionnaires could be completed by tele-
phone, with a member of the research team,
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Data analysis
We estimated the number of eligible patients from rou-
tinely recorded data. We recorded the number of poten-
tially eligible patients who consented to contact, the
number who were eligible, and the number who con-
sented to the study, were randomised and those who de-
clined. We conducted a descriptive analyses of the
baseline characteristics (median and inter-quartile
range). We described the group mean (95% confidence
intervals) for the 6-month outcome in both groups. Ana-
lysis is presented of available cases following intention to
treat (ITT) principles. No hypothesis tests were con-
ducted because of the nature of the study as a feasibility
study.
Sample size
As the aim of this study was to assess the feasibility of a
future definitive trial, we did not undertake a formal
sample size calculation
Qualitative data collection and analysis
All recruitment consultations were routinely audio-
recorded, to document the interaction between recruiter
and potential participant to explore information
provision, recruitment techniques, patient treatment
preferences and randomisation decisions to identify re-
cruitment difficulties and support change. In-depth in-
terviews were undertaken with patients to determine the
acceptability of the study methods and the interventions
and with the GPs to determine the acceptability of the
recruitment methods. Interviews were semi-structured
following a checklist of topics to ensure consistency, but
flexible enough to allow GPs and patients to raise issues
of importance. Interviews lasted approximately 30 min
and all were audio-recorded with consent, transcribed
verbatim and anonymised.
Participants and GPs were given the option of a face-
to-face or telephone interview. Participants were inter-
viewed in their own home or GP surgery, and GPs were
interviewed in their place of work. Some participants
chose to provide brief telephone feedback (discussion
lasting less than 10 min) about their experiences because
they did not have time to discuss the full interview
schedule. When participants did not have time to take
part in an interview, they were asked to comment on
their experiences of the interventions and where appro-
priate, their reasons for discontinuing the EI programme
before the final session.
Qualitative data analysis was an ongoing and iterative
process commencing soon after data collection and in-
formed further sampling and data collection. Interview
transcripts and observation notes were imported into
NVivo where they were systematically assigned codes
and analysed thematically to identify themes using
techniques of constant comparison [17]. Individuals
exhibiting contrasting attitudes (‘negative cases’) were
studied in detail to understand reasons underlying such
contrasts and to gain a deeper understanding of the data
and findings.
Recruitment to study consultations were purposefully
selected for analysis at regular time points during the
study, according to whether or not the study participant
accepted randomisation, and those that highlighted is-
sues of study acceptability (intervention cross over and
study withdrawal) were also targeted for further analyses.
They were analysed for content and presentation of in-
formation relating to the interventions using techniques
of content analysis [18]. Two members of the research
team analysed approximately 10% of the qualitative data
independently to compare coding and enhance reliabil-
ity. Descriptive accounts were produced, and theoretical
explanations for behaviours, opinions and decisions
developed.
Serious adverse events (SAEs)
Serious adverse events were reported by clinicians from
the specialist clinical team, primary care or members of
the research team to the PI and the sponsor within 24 h.
All SAEs were reviewed by the Research and Innovation
Department at North Bristol NHS Trust.
Ethical review
A favourable opinion was obtained in June 2012, by the
South West 2 Local Research Ethics Committee.
At the end of November 2012, LREC approved a sub-
stantial amendment. This amendment allowed patients
to be informed about the study before their blood results
came back. In December 2012, information regarding
the new recruiting pathway was sent to GPs. This asked
GPs to provide patients with an informational leaflet at
the initial contact and then again once a normal blood
result was obtained. It was hoped this would improve
recruitment.
Results
Between July 2012 and December 2013, we recruited 14
GP practices to this study of which 13 practices referred
patients into the study. The 14 GP practices were spread
across all deprivation scores.
Of 90 potentially eligible patients referred to the study
(Fig. 1), 44 patients were recruited 11 either did not re-
spond to the invitation in the patient information sheet
(PIS) or were not given a PIS by the GP. See additional
file 2 for the CONSORT 2010 checklist of information
to include when reporting a feasibility study. Forty-six
patients did respond but were ineligible: 11 had been fa-
tigued for > 4 months; 7 had fatigue which had resolved
by the time they were approached about the study; 14
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had abnormal investigations (13 abnormal blood results and
one had a positive pregnancy test) which excluded a diagno-
sis of CFS/ME; three had not had all their blood tests com-
pleted. Of the 13 with abnormal blood test results, the most
common reason (n = 7) for exclusion was raised inflamma-
tory markers. Of the remaining six, one was anaemic; one
had high sodium; one had a raised haemoglobin, urea, creat-
ine kinase, and creatinine; one had high tissue transglutami-
nase antibodies suggesting coeliac disease; one had raised
thyroid-stimulating hormone (TSH); and another had raised
blood glucose levels (diabetes).
Of the 44 patients randomised, 16 patients were allo-
cated to usual care and 28 patients were allocated to
usual care plus EI. Of those patients allocated to EI, 19/
28 attended 4 sessions, and 9 were lost to follow-up (2
at session 1, 2 at session 2, 3 at session 3, 2 at session 4).
There were no losses to follow-up in the usual care arm.
We wanted to understand whether the problem with re-
cruitment was because there were no eligible patients. We
therefore explored this question by examining how many pa-
tients consulted their GP with fatigue. Data was provided by
11 of the 14 practices involved over the period of the study.
Between April 2012 and 30 June 2013, there were 1711 con-
sultations which included the codes: TATT/fatigue/malaise/
lethargy (see additional file 1).
Lack of compliance with the treatment arm
All 28 participants accepted the allocation at the ran-
domisation appointment. 16 usual care and 28 EI re-
ceived the treatment as allocated. Table 1 (Baseline
characteristics) shows that the EI treatment group were
slightly older (median age 40.0) than the control group
(median age 37.5) and had a lower proportion of females
(68% compared with 88%). Those allocated EI also had a
Fig. 1 CONSORT early intervention in fatigue study
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lower median SF-36 physical function score (67.5 com-
pared with 70.0), higher median pain score (32.5 com-
pared with 22.5), higher median HADS depression score
(8.5 compared with 6.5) and lower median HADS anx-
iety score (8.5 compared with 10.5). Chalder Fatigue
scores were similar in both groups.
While the median EQ5D-5L were similar between the
two groups, the EI treatment group had a lower percent-
age in paid work (64% compared with 81%), but similar
hours missed from work over the past 7 days due to
health problems and more hours missed from work over
the past 7 days due to other reasons (median 1.0 inter-
vention compared with 0 h control). These data can be
found in Table 2.
Outcomes
Return of follow-up questionnaires was generally low
but was marginally better at 6 months (primary time
point, see Table 3, 36/44 returned) compared to 3
months when only 35/44 returned any questionnaires
and only 34/44 (77%) returned the SF-36 physical
function sub-scale. We have not presented the 3 month
outcomes because we wanted to analyse the feasibility of
collecting 3-month outcomes for future mediation ana-
lyses in a full trial. Table 3 shows the change in fatigue,
pain, physical function (SF-36 physical function sub-
scale), anxiety, depression, quality of life and loss of
earnings data at 6 months. There was a reduction in
mean Chalder Fatigue score at 6 months in both groups
(control 14.7, intervention 12.3). There was no evidence
of any difference between the two treatment groups in
any of the clinical outcomes, but no statistical tests com-
pared the differences between the two groups on this
small sample of feasibility data.
There were no differences between the two groups in
mean number of hours missed from work due to health
problems or health problems affecting productivity.
Patient note review
In the 14 recruiting practices, 1711 patients were re-
corded as being tired all the time (TATT) or presenting
with fatigue, exhausted, malaise, and lethargy between 1
Table 1 Baseline characteristics
Baseline characteristics of the randomised population Treatment group
Control (n = 16) Intervention (n = 28)
Demographic data
Median (25th, 75th centiles) age 37.5 (29.5, 50.0) 40.0 (32.0, 47.0)
Number female (%) 14 (88) 19 (68)
Number white (%) 16 (100) 26 (93)
Clinical data (median (inter-quartile range))
SF-36 physical function score 70.0 (57.5, 95.0) 67.5 (42.5, 80.0)
Median Chalder Fatigue score (25th, 75th centiles) 24.5 (21.0, 26.0) 23.0 (20.0, 28.0)
Median pain VAS (25th, 75th centiles) 22.5 (0.0, 61.0) 32.5 (7.5, 62.5)
Median HADS Anxiety score (25th, 75th centiles) 10.5 (6.0,14.5) 8.5 (6.0, 12.0)
Median HADS Depression score (25th, 75th centiles) 6.5 (5.0, 9.0) 8.5 (4.5,10.5)
Table 2 Baseline economic characteristics
Baseline economic characteristics of the randomised population Treatment group
Control (n = 16) Intervention (n = 28)
EQ5D-5L
Median EQ5D-5L (25th, 75th centiles) 0.710 (0.581, 0.790) 0.716 (0.491, 0.811)
WPAI: GH 1
Number in paid work (%) 13 (81) 18 (64)
Median hours missed from work due to health problems in the past 7 days (25th, 75th centiles)* 0.0 (0.0, 4.0) 0.0 (0.0, 2.0)
Median hours missed from work due to other reasons in the past 7 days (25th, 75th centiles)* 0.0 (0.0, 7.5) 1.0 (0.0, 15.0)
Median hours worked in the past 7 days (25th, 75th centiles)* 30.0 (10.0, 40.0) 24.5 (16.0, 38.0)
Median health problems affected productivity while working in the past seven days (25th, 75th centiles)** 4.0 (3.0, 7.0) 4.0 (2.0, 6.0)
Median health problems affected productivity other than working in the past seven days (25th, 75th centiles) 6.0 (5.0, 8.0), n= 15 5.5 (3.5, 8.0)
*Only answered by those patients who are currently in paid work (13 in the control group, 18 in the intervention group)
**Only answered by those patients who are currently in paid work and worked more than 0 h in the past 7 days (11 in the control group, 17 in the
intervention group).
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April 2012 and 30 June 2013 (see additional file 1). In
the more detailed review, of the 100 records on EMIS
sampled retrospectively, 56 out of the 100 analysed, met
criteria for eligibility, as they did not have any other ex-
clusionary medical or psychological diagnosis to explain
the fatigue which had lasted between 1 and 4months,
however only 2 patients were recruited into the study.
Of the remaining 54 patients who appeared to be eligible
but were not recruited, one later developed CFS and one
developed post-viral fatigue syndrome.
Qualitative research findings
Recruitment consultations
Feedback was provided for the recruiter after the first
five recruitment consultations were analysed. Consulta-
tions were good in terms of pitching of information,
pace, invitation of questions, and the building of rapport,
and patients were accepting of the randomisation
process and their allocated intervention arms. The re-
search team was able to highlight areas where informa-
tion provision could be more balanced to promote
equipoise between treatment arms and support changes
to the way that information was presented and discussed
with potential participants. Instead of using statements
such as the following:
Recruiter: When people come into the study and
they either get the therapy or they just see the doc-
tor for their usual care
Information about the usual care arm was provided, in
addition to information about the early intervention:
Recruiter: Already GPs are able to do quite a lot of
things to help, they can run blood tests and exclude
other medical problems, they can refer onto other
specialists, they can help people with ways of man-
aging day-to-day
Instead of highlighting difficulty or the fact that some
participants would ‘just’ see the doctor, the recruiter was
encouraged to promote equipoise and equality between
study arms by highlighting the fact that there is cur-
rently a lack of evidence and we do not know if early
intervention is necessary or beneficial to patients with
early fatigue:
Recruiter: But we don’t know if an early interven-
tion will help ....... there is a chance say, by trying to
look at things early, it may be too early, and it may
have no effect or in some cases it may make some
people worse, we just don’t know
Participant feedback
Out of forty-four participants randomised, 20 partici-
pants were interviewed, 8/16 in the usual care arm and
12/28 in the EI arm. A further 10 participants gave brief
telephone feedback, (discussion lasting less than 10 min)
about their experiences because they did not have time
to discuss the full interview schedule (three in the usual
care arm and seven in the early intervention arm).
Twenty participants chose to discuss the study via tele-
phone, eight were interviewed in a place of their choice
and two provided feedback via email. Seventeen partici-
pants gave feedback 3 months after recruitment and thir-
teen gave feedback 6 months after recruitment. All 9
participants who dropped out of the intervention arm
were contacted; seven provided feedback on why they
had discontinued sessions and two did not respond to
contact.
Study documentation
Participants in both study arms found study documenta-
tion and processes acceptable. These participants were
happy with the amount of information they had been
given, felt it was understandable and clear, it didn’t con-
tain lots of ‘jargon’ (participant 11: male, < 40 years, early
Table 3 Six-month clinical and health economic outcomes
6-month clinical and health economic outcomes Control group mean
(95% confidence interval ), n
Intervention group mean
(95% confidence interval ), n
Chalder Fatigue score 14.7 (10.6, 18.9), 16 12.3 (9.3, 15.3), 20
Pain VAS 18.9 (5.8, 31.9), 16 22.1 (8.5, 35.7), 19
SF-36 physical function score 84.4 (72.4, 96.3), 16 76.8 (65.1, 88.4), 20
HADS Anxiety score 7.8 (4.9, 10.6), 16 7.8 (5.4, 10.3), 19
HADS Depression score 4.6 (2.9, 6.2), 16 4.9 (3.0, 6.9), 19
EQ-5D-5L score 0.77 (0.677, 0.870), 16 0.749 (0.643, 0.855), 19
h missed from work due to health problems in the past 7 days 1.8 (− 0.4, 4.1), 11 5.3 (− 2.5, 13.1), 15
Health problems affected productivity while working in the past 7 days 3.0 (1.6, 4.4), 12 1.8 (0.6, 3.0), 13
QALY Control group AUC (SD) (n = 16) Intervention group AUC (SD) (n = 20)
0.371 (0.326, 0.416) 0.346 (0.293, 0.400)
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intervention). One participant with dyslexia found the
information sheet ‘daunting’ (participant 10: female, <
40 years, usual care).
Participant 2: Well I understood it, (information
sheet) so if I can understand (laughs) yeah, yeah,
yeah. No, I mean, you know, I could understand it
all fine, not a problem. I don’t think you can give
too much information (female, > 40 years, usual
care)
All interviewed participants were happy with the in-
formation provided by the trial manager at the face-
to-face recruitment to study session. Participants dis-
cussed the informed consent process as an opportun-
ity to gain a more in-depth introduction to the study
and valued the opportunity to ask further questions.
Participants seemed to engage and relate to the pur-
pose of the study, including the possible benefits that
the study could have for them. Using questionnaires
at the recruitment meeting helped participants iden-
tify their symptoms giving them a sense that these
symptoms were legitimate.
Participant 6: Um yeah I was quite encouraged be-
cause um I think it helped to articulate the deficit in
energy. Rather than thinking of, ‘Oh I’m tired all the
time,’ um it was good to think about sort of what is
different, what doesn’t work quite as well? (female,
> 40 years, usual care)
Interventions
Most participants (twelve) found parts of the interven-
tion acceptable, but fifteen reported one or more prob-
lems with acceptability. Parts of the intervention which
participants found positive and useful included the fact
that it encouraged self-reflection, the identification of
areas in their life where they may be putting themselves
under unnecessary pressure and restoring balance in
their work and home life.
Participant 11: In that space of time (while complet-
ing the intervention) um I was consciously looking
at myself because of the study, I have to concede…
and um – and all for the better. And not only that,
I’ve stayed with it as well. (male, < 40 years, early
intervention)
Participants felt that the intervention gave them
‘tips’ and ‘tools’ they could take forward and use in
the future. However, the timing of the intervention in
each participant’s illness varied, some felt they had
already started to make these positive changes them-
selves before they started the intervention, these
participants were unsure if they could attribute reduc-
tion in fatigue to the intervention. A small minority
identified the techniques used as cognitive behavioural
therapy (CBT).
Participant 9: Um and obviously it’s then hard to
know whether it’s the study that’s had that impact
or whether it was a time thing and it would have –
it would have sort of cleared itself away. (female, <
40 years, early intervention)
Others felt they were still experiencing fatigue when
the intervention came to an end, and two felt that they
were ‘left’ to manage their symptoms on their own when
the intervention ended.
Participant 23: Now I’ve had my last sort of chat
with (early intervention practitioner) um, you know,
my issues are still going on, albeit not as bad as
what they were, but now I have no contact with
anyone so I’m sort of out on me own with it now.
(male, > 40 years, early intervention)
Participants who discontinued the intervention or
found it particularly problematic did not relate to the
therapeutic model, disliked telephone consultations or
found the concept of self-reflection challenging.
Participant 25: I’ve not received any treatment (in
the early intervention arm) the psychology pamphlet
didn’t have any practical application to my role
(work) or life... if you have heavy lifting work then
you need to do get someone else who is younger to
do it. It relied heavily on mood making; if you feel
like that, try to change the way you feel by doing
this, so you feel different kind of thing (male > 40
years, early intervention)
Participant 1: The one-to-one session at the surgery
was ok, but the ones on the telephone were no good
so I didn’t want to carry on with it (male > 40 years,
early intervention)
Participants suggested that the intervention could be
improved by making it more consistent and tailored to
the individual and that it could be delivered more flex-
ibly (e.g. by offering weekend and evening contact
appointments).
Participant 15: I just didn’t feel it was consistent. I
know, I know that she only had the 20 min to go
through it with me...and I thought it was a really
good plan, and it has helped me, but it hasn’t helped
me as much as I hoped it would. ..but I think part
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of that reason is because it wasn’t tailored to the in-
dividual. (female > 40 years, early intervention)
Sixty-four per cent (18/28) of participants in the inter-
vention arm were in paid employment, and some of
those interviewed reported that arranging telephone
follow-up sessions around their hours of employment
was challenging.
Participant 17: It has been difficult arranging the
phone consults. It has been difficult. Yeah, yeah I
mean I’m not blaming (early intervention practi-
tioner) at all. Um but that’s just how it’s worked
out, it hasn’t worked out well for either of us to
keep it on schedule (female > 40 years, early
intervention)
There were mixed views about whether or not 20–30-
min telephone intervention consultations were long
enough.
Participant 11: They were set in stone 20 to 30min,
30 min absolute max, sort of thing. And, yeah, if it
slipped ever so slightly over 30 min that was down
to me chatting probably. (laughs) But er – but yeah,
no, they were – they were perfect really…I was
thinking, ‘I ain’t sure I could make that last 20 min,’
but it was no problem at all. So – so yeah, so, you
know, um the length of time was pretty good (male,
< 40 years, early intervention)
Participant 15: I know what she was saying, and I
know the advice, but because it was such – it was
only a 20-min phone call, there wasn’t the oppor-
tunity…basically the phone calls needed to be longer
(female > 40 years, early intervention)
The feedback from participants in the usual care arm of
the study suggested variation in GP guidance in relation
to symptom management and recognition of fatigue
symptoms. One participant felt that their GP had taken
their symptoms seriously, but some participants in the
usual care study arm were disappointed that they were
not receiving the early intervention programme and devel-
oped ways of managing their fatigue on their own. Two
participants in the usual care study arm were later referred
to the CFS/ME service by their GPs for further treatment.
Participant 6: I was disappointed to not get into the
um – be selected for the other group. Um mainly be-
cause I think presenting to your doctor with this is
quite difficult. I certainly felt I needed to be assertive
in saying I’d like these tests, I’m not – you know, er I
want something, er not – not necessarily drugs, but I
want some exploration....I was heard but maybe not
listened to initially (female > 40 years, usual care)
Participant 10: I’ve been taking amphetamine when
I have to, to get me through the day …I went to the
doctor’s for help but I just felt like I was brushed
off. (female < 40 years, usual care)
GP feedback
Qualitative interview data from GPs referring and
recruiting to the early intervention study documented
GP views of screening and study processes and explored
the treatment options offered to patients presenting with
early fatigue in primary care. Interviews were conducted
with 12 GPs from 10 of the participating practices,
representing a range of socio-economic areas, (three
practices did not respond to requests to discuss the
study and one practice declined).
The majority of GPs interviewed felt that the GP informa-
tion sheet was acceptable and understood the recruitment
process, 3 commented on the laminated flowchart being a
useful point of reference. GPs reported a clear understanding
of the study and their feeling that the study was worthwhile
for patients experiencing short-term fatigue.
I mean I think the paperwork is really fine and easy
to follow. And I think it’s a really good option for
people, because often there’s not that much you can
offer people (GP4 practice 11)
It was a very straightforward study to recruit into
once you identified the patients (GP12 practice 13)
The majority (10/12) of GPs cited a general lack of pa-
tients fitting the study eligibility criteria as the main diffi-
culty in referring the expected numbers of patients to the
feasibility study for recruitment. The eligibility criteria
were seen as limiting because the ‘window of opportunity’
that GPs had to identify and refer patients was too narrow
(more than one, but less than 4months of fatigue).
Yeah it’s not – it’s not – you know, tired all the
time is a recognised general practice sort of symp-
tom, but er, you know, I have been surprised that I
haven’t seen any (GP5 practice 2)
All 12 GPs discussed the importance of blood screens
to exclude physical causes of fatigue, but few of the GPs
involved routinely carried out the full range of screening
needed for the early intervention study. Only 1 GP said
the study bloods were standard.
There’s a couple I wouldn’t necessarily have nor-
mally done probably...I mean I think everybody
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probably has their pet bloods they take for tiredness
(GP2 practice 6)
We did have to tweak our – if we’ve got patients
who are tired all the time or have fatigue, we have a
set of bloods that we send them to the blood people
for...and they didn’t exactly match yours. We don’t
do all of the chronic fatigue bloods as a routine just
for normal fatigue that’s just been a month, we
wouldn’t (GP10 practice 10)
Study amendments to improve recruitment
In the first 3 months of recruitment, only 3 participants
were recruited from 11 GP practices compared to the
study target of 25 participants. To improve recruitment,
we asked GPs to inform potential participants about the
study at the GP appointment rather than waiting for
normal blood test results, changed the randomisation ra-
tio in favour of the EI, visited each practice, emailed
weekly updates, telephoned each practice weekly and
formally notified each practice when a patient was ac-
cepted into the study.
Serious adverse events (SAEs)
One SAE was reported during this study which was not
related to either intervention.
Discussion
Despite fatigue being one of the most common com-
plaints in general practice, this study shows that a trial
designed to identify patients with fatigue and offer early
treatment to prevent the development of CFS/ME is not
feasible or acceptable in primary care using this method-
ology. GPs found it hard to recruit to the study because
of difficulties identifying patients with fatigue between 1
and 4months onset and difficulties with obtaining the
correct screening blood test results. Not all patients
found the treatment offered acceptable.
Strengths and limitations
We recruited GP practices to represent the Bristol popu-
lation. This means that the results from this study may
not be generalisable to other regions in the UK or other
countries. Demographic data on the economic and work
status of the sample is provided in Table 2 (baseline eco-
nomic characteristics). We incorporated qualitative re-
search methods to enable us to investigate issues around
randomisation and retention as well as to explore expe-
riences of the early intervention treatment.
The level of fatigue documented by EMIS (1711 con-
sultations within the study period) is consistent with
previous studies [1, 2, 19, 20] which have suggested that
10–24% of patients attend their GP with fatigue as their
primary symptom. In our study, only 90 patients were
referred as potential participants. This could be for a
variety of reasons including the fact that the majority of
patients may have had fatigue for longer than 6months
(or less than 1 month), the difficulties GPs faced in iden-
tifying patients or a reluctance of patients to take part in
the study. This is not consistent with one study [6]
which successfully recruited patients after an episode of
EBV and provided self-help advice on implementing a
graded approach to exercise.
We considered recruiting participants after an infec-
tion but this would have limited the intervention to a
small group of patients. We are not aware of previous
studies that attempted to recruit participants with fa-
tigue of 1 to 4months duration. While it is possible that
patients were not eligible, this is not consistent with our
detailed notes review which suggested at least half of
those not recruited were eligible. Problems with identify-
ing patients in primary care for research trials has been
highlighted in other disease areas [3, 21].
Not all the participants found the intervention acceptable.
This is not consistent with previous trials in CFS/ME which
have shown a high level of patient satisfaction and low drop-
out rates with similar treatment approaches [22]. This may
be because the treatment sessions were much shorter (20
min) than the treatment sessions provided in specialist ser-
vices (and trials testing effectiveness) which are normally 60
min long [23]. We noted that most of the participants were
still in employment and that this is a different group of pa-
tients to those attending a specialist service where studies in-
dicate over 50% of patients are unemployed [24]. Follow-up
rates were relatively low but there is insufficient data to com-
ment on whether the timing of follow-up was appropriate.
Some patients found attending the sessions difficult as
they required appointments outside of work time and
did not want follow-up phone calls. This may be because
the early intervention needs to be adapted more for pa-
tients who are still working unlike those with CFS where
many patients are no longer in work.
Participants expressed dissatisfaction about the man-
agement offered for their fatigue by their GP which is
consistent with previous studies which have shown low
levels of patient satisfaction in patients reporting chronic
fatigue and chronic fatigue syndrome [25, 26]. There is
also evidence of the difficulties GPs feel in diagnosing
CFS/ME and dealing with patients that present with
fatigue [27].
We were surprised that approximately a third of par-
ticipants did not find the intervention acceptable. The
reasons given for this include issues around the self-
reflection required during the process and the partici-
pant not accepting the therapeutic model. It is possible
that treatment developed for patients with long-term fa-
tigue is not suitable or appropriate for those with fatigue
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lasting only 1 to 4 months, where a more traditional
medical model may be more prevalent.
Conclusions
CFS/ME is a significant health burden and preventing
the development of CFS/ME is likely to result in signifi-
cant savings to the NHS and improved quality of life for
those it affects [4, 24]. Expecting GPs to recruit to stud-
ies brings challenges and Primary Care Research Net-
works (PCRNs), now Clinical Research Networks, were
established to assist with recruitment by providing fund-
ing and sometimes personnel. Future studies should ex-
plore different recruitment mechanisms in GP surgeries
including list searchers and using PCRN-funded staff to
recruit patients as well as explore why GPs do not ap-
pear to feel that early intervention is helpful (and there-
fore refer into the study).
Further work needs to be done to develop an interven-
tion that is appropriate for this group of patients using
the methodology described in the MRC framework on
developing and evaluating complex interventions [28].
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